Clinical Trial Update: Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating mesenchymal stem cells for ischemic cardiomyopathy; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Alexandra Cristina Senegaglia | Conditions: Ischemic Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED